Crescent Biopharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CBIO Nasdaq 2830 crescentbiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Crescent Biopharma, Inc.

Huge Insider Buying in MGM and Salesforce - Dec 12th, 2025 7:45 am
Crescent and Kelun-Biotech swap cancer asset rights in double deal - Dec 5th, 2025 7:36 am
Praxis soars higher; Bristol Myers’ CAR-T therapy wins broader use - Dec 5th, 2025 3:00 am
Crescent Biopharma, Kelun-Biotech Biopharmaceutical Partner in Multimillion Dollar Deal to Develop Cancer Drugs - Dec 4th, 2025 5:13 am
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors - Dec 4th, 2025 4:35 am
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics - Dec 4th, 2025 4:30 am
Crescent Biopharma Announces Grants of Inducement Awards - Nov 17th, 2025 2:15 pm
Sickle Cell Disease Treatment Market Research Report 2025 Featuring Novartis, Pfizer, Bluebird Bio, GlycoMimetics, Emmaus Medical, BMS, CRISPR Therapeutics, Graphite Bio - Nov 11th, 2025 7:40 am
Crescent Biopharma: Q3 Earnings Snapshot - Nov 6th, 2025 5:40 am
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights - Nov 6th, 2025 5:30 am
Crescent Biopharma to Present at November Investor Conferences - Nov 5th, 2025 5:30 am
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Nov 4th, 2025 7:05 am
With 36% stake, Crescent Biopharma, Inc. (NASDAQ:CBIO) seems to have captured institutional investors' interest - Sep 17th, 2025 5:01 am
Crescent Biopharma to Present at September Investor Conferences - Aug 28th, 2025 5:30 am
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Jul 31st, 2025 5:34 am
Crescent Biopharma: Q2 Earnings Snapshot - Jul 31st, 2025 5:32 am
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer - Jul 8th, 2025 5:30 am